0001104659-23-090706.txt : 20230811
0001104659-23-090706.hdr.sgml : 20230811
20230811211741
ACCESSION NUMBER: 0001104659-23-090706
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230809
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vellanki Avanish
CENTRAL INDEX KEY: 0001856682
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40356
FILM NUMBER: 231165893
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rain Oncology Inc.
CENTRAL INDEX KEY: 0001724979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821130967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: (510) 953-5559
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: Rain Therapeutics Inc.
DATE OF NAME CHANGE: 20171211
4
1
tm2323614-10_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-09
0
0001724979
Rain Oncology Inc.
RAIN
0001856682
Vellanki Avanish
C/O RAIN ONCOLOGY INC.
8000 JARVIS AVENUE, SUITE 204
NEWARK
CA
94560
1
1
0
0
Chairman and CEO
0
Stock Option (Right to Buy)
1.21
2023-08-09
4
A
0
266500
0.00
A
2033-08-09
Common Stock
266500
266500
D
Stock Option (Right to Buy)
1.21
2023-08-09
4
A
0
133250
0.00
A
2033-08-09
Common Stock
133250
133250
D
This option represents a right to purchase a total of 266,500 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the Reporting Person's continued service to the Issuer.
This option represents a right to purchase a total of 133,250 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the achievement of certain corporate goals and the Reporting Person's continued service to the Issuer.
/s/ Avanish Vellanki
2023-08-11